These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 30287443)

  • 1. Lesson of the month 1: Sodium valproate-induced encephalopathy.
    Camilleri L
    Clin Med (Lond); 2018 Oct; 18(5):430-432. PubMed ID: 30287443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valproate-induced hyperammonemic encephalopathy treated by L-ornithine-L-aspartate: a case report.
    Yu-E Y; Zhi-Qin L; Hui L; Zheng-Li D; Fang Z; Fang Y
    Clin Med (Lond); 2023 May; 23(3):271-274. PubMed ID: 37236802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium valproate-related hyperammonaemic encephalopathy.
    Pegg EJ; Zaman F
    BMJ Case Rep; 2014 Apr; 2014():. PubMed ID: 24722719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-hyperammonaemia valproate-induced encephalopathy: A case report.
    Chen L; Xu Z; Huang H
    J Clin Pharm Ther; 2022 Mar; 47(3):415-419. PubMed ID: 34462930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case report of valproate encephalopathy].
    Miyamoto T; Miyamoto M; Hirata K; Katayama S
    Rinsho Shinkeigaku; 1999 Oct; 39(10):1075-7. PubMed ID: 10655774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Valproate-associated hyperammonemic encephalopathy. Report of one case].
    Young P; Finn BC; Alvarez F; Bruetman JE; Trimarchi H
    Rev Med Chil; 2007 Nov; 135(11):1446-9. PubMed ID: 18259656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Valproic acid-induced hyperammonemic encephalopathy in a patient receiving valproic acid monotherapy].
    Yamada H; Shishido T; Mukai T; Araki M; Naka H; Tokinobu H
    Rinsho Shinkeigaku; 2019 May; 59(5):258-263. PubMed ID: 31061301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ammonia and carnitine concentrations in children treated with sodium valproate compared with other anticonvulsant drugs.
    Thom H; Carter PE; Cole GF; Stevenson KL
    Dev Med Child Neurol; 1991 Sep; 33(9):795-802. PubMed ID: 1936631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: relationship to blood carnitine status.
    Hamed SA; Abdella MM
    Epilepsy Res; 2009 Sep; 86(1):32-41. PubMed ID: 19446440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Report of three cases of hyperammonaemic encephalopathy associated with valproic acid due to possible synergism with phenobarbital and topiramate].
    Cano-Zuleta A; Hernández-Ortíz OH; González-González CA; Amariles P
    Farm Hosp; 2012; 36(5):441-2. PubMed ID: 22266198
    [No Abstract]   [Full Text] [Related]  

  • 11. Valproate-induced hyperammonemic encephalopathy in a renal transplanted patient.
    Melexopoulou C; Marinaki S; Darema M; Skalioti C; Efthimiou A; Zavos G; Boletis JN
    Ren Fail; 2014 Jul; 36(6):955-6. PubMed ID: 24665854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproic acid induced hyperammonaemic encephalopathy.
    Amanat S; Shahbaz N; Hassan Y
    J Pak Med Assoc; 2013 Jan; 63(1):72-5. PubMed ID: 23865136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproate-induced hyperammonemia - uncovering an underlying inherited metabolic disorder: a case report.
    Mehta S; Tayabali S; Lachmann R
    J Med Case Rep; 2018 May; 12(1):134. PubMed ID: 29769109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valproate-induced Hyperammonemic Encephalopathy Presenting as Catatonia.
    Pérez-Esparza R; Oñate-Cadena N; Ramírez-Bermúdez J; Espínola-Nadurille M
    Neurologist; 2018 Mar; 23(2):51-52. PubMed ID: 29494435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valproate-Associated Hyperammonaemic Encephalopathy.
    Anthonipillai P; Sharp G; Kimber J; Ziauddin V
    Acute Med; 2022; 21(1):43-46. PubMed ID: 35342909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topiramate-valproate-induced hyperammonemic encephalopathy syndrome: case report.
    Cheung E; Wong V; Fung CW
    J Child Neurol; 2005 Feb; 20(2):157-60. PubMed ID: 15794187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Valproate can induce reversible encephalopathy].
    Prakash S; Harbo T; Christensen J
    Ugeskr Laeger; 2014 Nov; 176(45):. PubMed ID: 25394838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe acute hyperammonemia after brief exposure to valproate.
    Eubanks AL; Aguirre B; Bourgeois JA
    Psychosomatics; 2008; 49(1):82-3. PubMed ID: 18212182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproate-induced encephalopathy in a comorbid elderly woman.
    Gandolfo F; Parodi MN; Corsini GP; Odetti P; Serafini G; Monacelli F
    Psychogeriatrics; 2017 May; 17(3):208-209. PubMed ID: 28093879
    [No Abstract]   [Full Text] [Related]  

  • 20. Reversible weakness and encephalopathy while on long-term valproate treatment due to carnitine deficiency.
    Al-sharefi A; Bilous R
    BMJ Case Rep; 2015 Sep; 2015():. PubMed ID: 26336183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.